Cancer Center Support Grant - P30

癌症中心支持补助金 - P30

• 批准号: 7931101
• 负责人: Ralph W. deVere White
• 金额: $ 145.06万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2011-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7931101
• 关键词: Achievement; Advanced Malignant Neoplasm; California; Cancer Center; Cancer Center Support Grant; Clinical Trials; Future; Geography; Investigation; Laboratories; Leadership; Malignant Neoplasms; NCI-Designated Cancer Center; Phase; Population; Provider; anticancer research; cancer care; programs; ranpirnase

DESCRIPTION (provided by applicant): The UC Davis Cancer Center, the only NCI-designated cancer center in the Central Valley of California, is the advanced cancer care provider for a population of five million, the only significance point of access to early phase cancer clinical trials in its Northern California region, and together with its collaborator, the Lawrence Livermore National Laboratory [LLNL], the region's principal cancer research organization. Since its founding thirteen years ago, the UC Davis Cancer Center has provided increasingly progressive leadership to, organization of, and support for cancer investigation. In the first sections, we recapitulate briefly the milestones leading up to NCI designation (July 1, 2002). In subsequent sections, we focus on decisions, achievements, and directions characterizing the center's first two years of its Cancer Center Support Grant [CCSG]. In concluding sections, we focus on program and organizational accomplishments, future direction, and geography.

描述（申请人提供）：加州大学戴维斯分校癌症中心是加州中央谷唯一一家由国家癌症研究所指定的癌症中心，是500万人口的高级癌症护理提供者，也是北方加州地区进入早期癌症临床试验的唯一重要点，与其合作者劳伦斯利弗莫尔国家实验室[LLNL]一起，该地区主要的癌症研究组织。 自13年前成立以来，加州大学戴维斯分校癌症中心为癌症研究提供了日益进步的领导，组织和支持。 在第一部分中，我们简要地概括了导致NCI认定（2002年7月1日）的里程碑。 在随后的章节中，我们将重点介绍该中心在癌症中心支持补助金（CCSG）的前两年的决定、成就和方向。 在结论部分，我们将重点放在计划和组织的成就，未来的方向和地理。